Related Experiment Video
Updated: Aug 17, 2026

Efficient Production and Purification of Recombinant Murine Kindlin-3 from Insect Cells for Biophysical Studies
Published on: March 19, 2014
Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis
1Department of Biochemistry, Nagoya University School of Medicine, Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan. tmurama@med.nagoya-u.ac.jp
Abstract:
Midkine (MK) and pleiotrophin (PTN) are low molecular weight proteins with closely related structures. They are mainly composed of two domains held by disulfide bridges, and there are three antiparallel beta-sheets in each domain. MK and PTN promote the growth, survival, and migration of various cells, and play roles in neurogenesis and epithelial mesenchymal interactions during organogenesis. A chondroitin sulfate proteoglycan, protein-tyrosine phosphatase zeta (PTPzeta), is a receptor for MK and PTN. The downstream signaling system includes ERK and PI3 kinase. MK binds to the chondroitin sulfate portion of PTPzeta with high affinity. Among the various chondroitin sulfate structures, the E unit, which has 4,6-disulfated N-acetylgalactosamine, provides the strongest binding site. The expression of MK and PTN is increased in various human tumors, making them promising as tumor markers and as targets for tumor therapy. MK and PTN expression also increases upon ischemic injury. MK enhances the migration of inflammatory cells, and is involved in neointima formation and renal injury following ischemia. MK is also interesting from the viewpoints of the treatment of neurodegenerative diseases, increasing the efficiency of in vitro development, and the prevention of HIV infection.
Insights
Midkine (MK) and pleiotrophin (PTN) are proteins involved in cell growth and organ development. Their elevated expression in tumors and after injury suggests roles in disease and potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Midkine (MK) and pleiotrophin (PTN) are structurally similar low molecular weight proteins.
- They regulate cell growth, survival, migration, neurogenesis, and epithelial-mesenchymal interactions.
- Protein-tyrosine phosphatase zeta (PTPzeta) acts as a receptor for MK and PTN, activating downstream ERK and PI3 kinase signaling.
Purpose of the Study:
- To explore the biological functions and potential applications of Midkine (MK) and pleiotrophin (PTN).
- To investigate the binding characteristics of MK to its receptor PTPzeta.
- To highlight the significance of MK and PTN in pathological conditions and therapeutic strategies.
Main Methods:
- Structural analysis of MK and PTN.
- Investigation of cell signaling pathways (ERK, PI3 kinase).
- Binding affinity studies using chondroitin sulfate structures.
Main Results:
- MK and PTN promote cell growth, survival, and migration.
- The E unit of chondroitin sulfate on PTPzeta provides a high-affinity binding site for MK.
- Increased expression of MK and PTN is observed in human tumors and following ischemic injury.
Conclusions:
- MK and PTN are implicated in tumor progression and ischemic injury.
- Their roles in cell migration and inflammation suggest involvement in neointima formation and renal injury.
- MK and PTN hold potential as tumor markers, therapeutic targets, and in treating neurodegenerative diseases, enhancing in vitro development, and preventing HIV infection.
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

